Cita APA

Shi, H., Xu, J., Lang, X., Wu, H. E., Xiu, M. H., Zhang, X. Y., & Zhang, X. Y. (2022). Comparison of Efficacy and Safety Between Low-Dose Ziprasidone in Combination With Sertraline and Ziprasidone Monotherapy for Treatment-Resistant Patients With Acute Exacerbation Schizophrenia: A Randomized Controlled Trial. Frontiers Media S.A.

Chicago Style Citation

Shi, Hui, Jing Xu, Xiaoe Lang, Hanjing Emily Wu, Mei Hong Xiu, Xiang Yang Zhang, i Xiang Yang Zhang. Comparison of Efficacy and Safety Between Low-Dose Ziprasidone in Combination With Sertraline and Ziprasidone Monotherapy for Treatment-Resistant Patients With Acute Exacerbation Schizophrenia: A Randomized Controlled Trial. Frontiers Media S.A, 2022.

Cita MLA

Shi, Hui, et al. Comparison of Efficacy and Safety Between Low-Dose Ziprasidone in Combination With Sertraline and Ziprasidone Monotherapy for Treatment-Resistant Patients With Acute Exacerbation Schizophrenia: A Randomized Controlled Trial. Frontiers Media S.A, 2022.